ZA866917B - Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same - Google Patents
Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing sameInfo
- Publication number
- ZA866917B ZA866917B ZA866917A ZA866917A ZA866917B ZA 866917 B ZA866917 B ZA 866917B ZA 866917 A ZA866917 A ZA 866917A ZA 866917 A ZA866917 A ZA 866917A ZA 866917 B ZA866917 B ZA 866917B
- Authority
- ZA
- South Africa
- Prior art keywords
- weight
- acid derivatives
- medication
- transdermal
- propionic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853532562 DE3532562A1 (de) | 1985-09-12 | 1985-09-12 | Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA866917B true ZA866917B (en) | 1987-05-27 |
Family
ID=6280783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA866917A ZA866917B (en) | 1985-09-12 | 1986-09-11 | Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4849418A (es) |
| EP (1) | EP0215423B1 (es) |
| JP (1) | JPH078786B2 (es) |
| AT (1) | ATE63220T1 (es) |
| CA (1) | CA1269328A (es) |
| DE (2) | DE3532562A1 (es) |
| ES (1) | ES2002140A6 (es) |
| NO (1) | NO172028C (es) |
| YU (1) | YU46012B (es) |
| ZA (1) | ZA866917B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8701392D0 (en) * | 1987-01-22 | 1987-02-25 | Boots Co Plc | Therapeutic agents |
| US5104656A (en) * | 1989-06-16 | 1992-04-14 | Seth Pyare L | Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent |
| US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| US5210099A (en) * | 1991-02-11 | 1993-05-11 | American Home Products Corporation | Analgesic compositions |
| US5308621A (en) * | 1991-02-18 | 1994-05-03 | Commonwealth Scientific And Industrial Research Organisation | Ascorbic acid composition and transdermal administration method |
| DE4140183C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Retardform für ein Flurbiprofen enthaltendes Arzneimittel |
| DE4140185C2 (de) * | 1991-12-05 | 1996-02-01 | Alfatec Pharma Gmbh | Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung |
| DE4140184C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Flurbiprofen enthaltendes Arzneimittel |
| DE4140172C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Retardform für ein Ibuprofen enthaltendes Arzneimittel |
| JPH07503952A (ja) * | 1992-02-12 | 1995-04-27 | ジヤンセン・シラグ・ソチエタ・ペル・アチオニ | リポソームピロキシカム組成物 |
| EP0625898B1 (en) * | 1992-02-12 | 1996-05-15 | JANSSEN-CILAG S.p.A. | Liposomal piroxicam formulations |
| WO1993015719A1 (en) * | 1992-02-12 | 1993-08-19 | Janssen Farmaceutici S.P.A. | Liposomal itraconazole formulations |
| CN1106259A (zh) * | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
| JP3782834B2 (ja) * | 1994-10-26 | 2006-06-07 | 株式会社トクホン | 鎮痛抗炎症貼付剤 |
| US5702720A (en) * | 1995-12-22 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of flurbiprofen |
| CA2352964C (en) | 1998-12-01 | 2006-10-17 | University Of Kentucky Research Foundation | A method for enhancing protective cellular responses to genotoxic stress in skin |
| WO2001019329A2 (en) * | 1999-09-11 | 2001-03-22 | The Procter & Gamble Company | Polyoxyalkylene copolymers containing pourable liquid vehicles |
| DE10001096A1 (de) * | 2000-01-13 | 2001-07-26 | Lohmann Therapie Syst Lts | TTS mit Reservoirschicht zur Aufnahme und Abgabe von Duftstoffen |
| US7138133B2 (en) * | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
| CA2486553C (en) * | 2002-06-17 | 2012-01-10 | Taro Pharmaceuticals U.S.A., Inc. | Ibuprofen suspension |
| DE102005019628A1 (de) * | 2005-04-26 | 2006-11-09 | Technische Universität Braunschweig | Formulierung zur dermalen Anwendung |
| DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
| US20080317684A1 (en) * | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
| ATE468106T1 (de) * | 2007-04-19 | 2010-06-15 | August Wolff Gmbh & Co Kg Arzn | Gel zur behandlung von wunden |
| GB0921686D0 (en) * | 2009-12-11 | 2010-01-27 | Reckitt Benckiser Healthcare I | Topical formulation |
| DK2704703T3 (da) | 2011-05-03 | 2019-10-14 | Aponia Laboratories Inc | Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf |
| NZ606177A (en) * | 2012-01-30 | 2014-03-28 | Dolorgiet Gmbh & Co Kg | Compositions for the treatment of actinic keratosis |
| EP3213744A1 (de) * | 2016-03-01 | 2017-09-06 | Chemische Fabrik Kreussler & Co. Gmbh | Galenische zubereitung von nsaid |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) * | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| DE1617480B2 (de) * | 1967-08-01 | 1973-02-01 | Farbwerke Hoechst AG, vormals Mei ster Lucius & Brunmg, 6000 Frankfurt | Gelgrundlagen |
| US4100271A (en) * | 1976-02-26 | 1978-07-11 | Cooper Laboratories, Inc. | Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes |
| JPS5829706A (ja) * | 1981-08-14 | 1983-02-22 | Toko Yakuhin Kogyo Kk | 消炎鎮痛外用剤 |
| DE3205504C2 (de) * | 1982-02-16 | 1983-12-01 | Dolorgiet Gmbh & Co Kg, 5300 Bonn | Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel |
| JPS59222409A (ja) * | 1983-06-01 | 1984-12-14 | Nippon Redarii Kk | 消炎鎮痛ゲル軟膏剤 |
| US4511563A (en) * | 1983-07-15 | 1985-04-16 | Basf Wyandotte Corporation | Clear analgesic gels with reduced tackiness |
| JPS60209515A (ja) * | 1984-04-03 | 1985-10-22 | Hokuriku Seiyaku Co Ltd | 消炎鎮痛クリ−ム剤 |
| JPS6127920A (ja) * | 1984-07-16 | 1986-02-07 | Akiyoshi Masataka | 消炎鎮痛性外用医薬組成物 |
| DE3437599C2 (de) * | 1984-10-13 | 1987-04-16 | Dolorgiet GmbH & Co KG, 5205 St Augustin | Ibuprofen enthaltende Weichgelatinekapseln |
-
1985
- 1985-09-12 DE DE19853532562 patent/DE3532562A1/de not_active Withdrawn
-
1986
- 1986-07-16 YU YU126186A patent/YU46012B/sh unknown
- 1986-09-02 JP JP61206678A patent/JPH078786B2/ja not_active Expired - Lifetime
- 1986-09-08 CA CA000517670A patent/CA1269328A/en not_active Expired - Lifetime
- 1986-09-09 DE DE8686112457T patent/DE3679128D1/de not_active Expired - Lifetime
- 1986-09-09 AT AT86112457T patent/ATE63220T1/de not_active IP Right Cessation
- 1986-09-09 EP EP86112457A patent/EP0215423B1/de not_active Expired - Lifetime
- 1986-09-11 NO NO863636A patent/NO172028C/no not_active IP Right Cessation
- 1986-09-11 ZA ZA866917A patent/ZA866917B/xx unknown
- 1986-09-11 ES ES8601785A patent/ES2002140A6/es not_active Expired
-
1987
- 1987-11-16 US US07/101,532 patent/US4849418A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0215423B1 (de) | 1991-05-08 |
| ES2002140A6 (es) | 1988-07-16 |
| YU46012B (sh) | 1992-12-21 |
| DE3532562A1 (de) | 1987-03-12 |
| CA1269328A (en) | 1990-05-22 |
| ATE63220T1 (de) | 1991-05-15 |
| EP0215423A2 (de) | 1987-03-25 |
| JPS6261917A (ja) | 1987-03-18 |
| NO172028C (no) | 1993-06-02 |
| NO863636D0 (no) | 1986-09-11 |
| EP0215423A3 (en) | 1988-03-23 |
| NO172028B (no) | 1993-02-22 |
| JPH078786B2 (ja) | 1995-02-01 |
| US4849418A (en) | 1989-07-18 |
| YU126186A (en) | 1989-10-31 |
| DE3679128D1 (de) | 1991-06-13 |
| NO863636L (no) | 1987-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA866917B (en) | Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same | |
| BG60102B2 (bg) | Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол | |
| IE940583L (en) | Topical antimicrobial pharmaceutical compositions | |
| AU2905092A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| CA2039197A1 (en) | Pharmaceutic Formulation for the Treatment of Alcoholism | |
| CA2058428A1 (en) | Analgesic formulations | |
| DK0724885T3 (da) | Pernasal sammensætning og pernasalt præparat indeholdende dette | |
| DK0582239T3 (da) | Farmaceutisk og/eller kosmetisk formulering | |
| CA2107669A1 (en) | Preparation for treating wounds and hemorrhoides | |
| DK0617623T3 (da) | Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling | |
| DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
| BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
| IE873367L (en) | Ranitidine-ethanol formulation | |
| AU6756287A (en) | Nicorandil-containing preparation for injection | |
| AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
| WO1994022441A3 (en) | Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases | |
| ES2039377T3 (es) | Un supositorio. | |
| IE791995L (en) | Formulation | |
| IT1204400B (it) | Composizioni farmaceutiche contenente una calcitonina | |
| NO973401L (no) | Kortikosteroidinneholdende sammensetninger og fremstilling derav | |
| ZA91115B (en) | Topical compositions | |
| GR1000429B (el) | Συνθεση με βαση την τριμεβουτινη παρατεταμενης απελευθερωσης και μεθοδος παρασκευης της. | |
| EP0056681A3 (en) | Levonantradol and n-methyllevonantradol formulations | |
| MY101266A (en) | Pharmaceutical formulations | |
| EP0389773A3 (de) | Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO) |